Logo image of 1EXPE.MI

EXPEDIA GROUP INC (1EXPE.MI) Stock Fundamental Analysis

Europe - BIT:1EXPE - US30212P3038 - Common Stock

182.66 EUR
+13.22 (+7.8%)
Last: 8/25/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, 1EXPE scores 5 out of 10 in our fundamental rating. 1EXPE was compared to 53 industry peers in the Hotels, Restaurants & Leisure industry. 1EXPE has an excellent profitability rating, but there are some minor concerns on its financial health. 1EXPE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

1EXPE had positive earnings in the past year.
1EXPE had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: 1EXPE reported negative net income in multiple years.
Of the past 5 years 1EXPE 4 years had a positive operating cash flow.
1EXPE.MI Yearly Net Income VS EBIT VS OCF VS FCF1EXPE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

With a Return On Assets value of 4.10%, 1EXPE perfoms like the industry average, outperforming 58.62% of the companies in the same industry.
The Return On Equity of 1EXPE (132.42%) is better than 100.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 17.00%, 1EXPE belongs to the top of the industry, outperforming 87.93% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1EXPE is in line with the industry average of 10.61%.
The 3 year average ROIC (10.99%) for 1EXPE is below the current ROIC(17.00%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.1%
ROE 132.42%
ROIC 17%
ROA(3y)3.61%
ROA(5y)-0.96%
ROE(3y)48.88%
ROE(5y)5.49%
ROIC(3y)10.99%
ROIC(5y)N/A
1EXPE.MI Yearly ROA, ROE, ROIC1EXPE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

1EXPE's Profit Margin of 7.90% is fine compared to the rest of the industry. 1EXPE outperforms 65.52% of its industry peers.
In the last couple of years the Profit Margin of 1EXPE has grown nicely.
The Operating Margin of 1EXPE (12.15%) is better than 63.79% of its industry peers.
In the last couple of years the Operating Margin of 1EXPE has grown nicely.
With an excellent Gross Margin value of 89.58%, 1EXPE belongs to the best of the industry, outperforming 87.93% of the companies in the same industry.
1EXPE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.15%
PM (TTM) 7.9%
GM 89.58%
OM growth 3Y58.59%
OM growth 5Y8.82%
PM growth 3YN/A
PM growth 5Y14%
GM growth 3Y2.82%
GM growth 5Y1.74%
1EXPE.MI Yearly Profit, Operating, Gross Margins1EXPE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1EXPE is creating value.
Compared to 1 year ago, 1EXPE has less shares outstanding
Compared to 5 years ago, 1EXPE has less shares outstanding
Compared to 1 year ago, 1EXPE has an improved debt to assets ratio.
1EXPE.MI Yearly Shares Outstanding1EXPE.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
1EXPE.MI Yearly Total Debt VS Total Assets1EXPE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 1.15, we must say that 1EXPE is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.15, 1EXPE is in line with its industry, outperforming 41.38% of the companies in the same industry.
The Debt to FCF ratio of 1EXPE is 3.11, which is a good value as it means it would take 1EXPE, 3.11 years of fcf income to pay off all of its debts.
1EXPE has a Debt to FCF ratio of 3.11. This is in the better half of the industry: 1EXPE outperforms 77.59% of its industry peers.
A Debt/Equity ratio of 5.34 is on the high side and indicates that 1EXPE has dependencies on debt financing.
1EXPE has a Debt to Equity ratio of 5.34. This is in the lower half of the industry: 1EXPE underperforms 68.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.34
Debt/FCF 3.11
Altman-Z 1.15
ROIC/WACC2.05
WACC8.31%
1EXPE.MI Yearly LT Debt VS Equity VS FCF1EXPE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B 8B

2.3 Liquidity

A Current Ratio of 0.75 indicates that 1EXPE may have some problems paying its short term obligations.
The Current ratio of 1EXPE (0.75) is worse than 60.34% of its industry peers.
1EXPE has a Quick Ratio of 0.75. This is a bad value and indicates that 1EXPE is not financially healthy enough and could expect problems in meeting its short term obligations.
1EXPE has a Quick ratio of 0.75. This is comparable to the rest of the industry: 1EXPE outperforms 41.38% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
1EXPE.MI Yearly Current Assets VS Current Liabilites1EXPE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.29% over the past year.
Measured over the past years, 1EXPE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.87% on average per year.
1EXPE shows a small growth in Revenue. In the last year, the Revenue has grown by 5.69%.
The Revenue has been growing slightly by 2.56% on average over the past years.
EPS 1Y (TTM)21.29%
EPS 3Y104.08%
EPS 5Y14.87%
EPS Q2Q%20.8%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y16.77%
Revenue growth 5Y2.56%
Sales Q2Q%6.41%

3.2 Future

The Earnings Per Share is expected to grow by 15.50% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.25% on average over the next years.
EPS Next Y18.05%
EPS Next 2Y17.92%
EPS Next 3Y17.55%
EPS Next 5Y15.5%
Revenue Next Year5.46%
Revenue Next 2Y5.98%
Revenue Next 3Y6.57%
Revenue Next 5Y6.25%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1EXPE.MI Yearly Revenue VS Estimates1EXPE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
1EXPE.MI Yearly EPS VS Estimates1EXPE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.24 indicates a correct valuation of 1EXPE.
Based on the Price/Earnings ratio, 1EXPE is valued cheaply inside the industry as 84.48% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.27, 1EXPE is valued a bit cheaper.
The Price/Forward Earnings ratio is 12.55, which indicates a correct valuation of 1EXPE.
Based on the Price/Forward Earnings ratio, 1EXPE is valued cheaply inside the industry as 84.48% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of 1EXPE to the average of the S&P500 Index (22.77), we can say 1EXPE is valued slightly cheaper.
Industry RankSector Rank
PE 16.24
Fwd PE 12.55
1EXPE.MI Price Earnings VS Forward Price Earnings1EXPE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1EXPE is valued a bit cheaper than the industry average as 68.97% of the companies are valued more expensively.
1EXPE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. 1EXPE is cheaper than 67.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.24
EV/EBITDA 9.97
1EXPE.MI Per share data1EXPE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50

4.3 Compensation for Growth

1EXPE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1EXPE has a very decent profitability rating, which may justify a higher PE ratio.
1EXPE's earnings are expected to grow with 17.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.9
PEG (5Y)1.09
EPS Next 2Y17.92%
EPS Next 3Y17.55%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.74%, 1EXPE is not a good candidate for dividend investing.
1EXPE's Dividend Yield is a higher than the industry average which is at 3.03.
Compared to an average S&P500 Dividend Yield of 2.38, 1EXPE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.74%

5.2 History

Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

DPN/A
EPS Next 2Y17.92%
EPS Next 3Y17.55%
1EXPE.MI Yearly Income VS Free CF VS Dividend1EXPE.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

EXPEDIA GROUP INC

BIT:1EXPE (8/25/2025, 7:00:00 PM)

182.66

+13.22 (+7.8%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners100.21%
Inst Owner ChangeN/A
Ins Owners0.49%
Ins Owner ChangeN/A
Market Cap22.60B
Analysts72.56
Price Target196.67 (7.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.74%
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.21%
Min EPS beat(2)1.46%
Max EPS beat(2)20.96%
EPS beat(4)3
Avg EPS beat(4)9.14%
Min EPS beat(4)-0.95%
Max EPS beat(4)20.96%
EPS beat(8)7
Avg EPS beat(8)30.51%
EPS beat(12)8
Avg EPS beat(12)-12.48%
EPS beat(16)12
Avg EPS beat(16)3.75%
Revenue beat(2)1
Avg Revenue beat(2)-1.36%
Min Revenue beat(2)-2.83%
Max Revenue beat(2)0.11%
Revenue beat(4)2
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-3.22%
Max Revenue beat(4)1.66%
Revenue beat(8)3
Avg Revenue beat(8)-0.81%
Revenue beat(12)3
Avg Revenue beat(12)-1.4%
Revenue beat(16)5
Avg Revenue beat(16)-0.63%
PT rev (1m)-4.28%
PT rev (3m)-4.28%
EPS NQ rev (1m)1.86%
EPS NQ rev (3m)1.86%
EPS NY rev (1m)-0.74%
EPS NY rev (3m)-0.74%
Revenue NQ rev (1m)-0.59%
Revenue NQ rev (3m)-0.59%
Revenue NY rev (1m)-1.08%
Revenue NY rev (3m)-1.08%
Valuation
Industry RankSector Rank
PE 16.24
Fwd PE 12.55
P/S 1.89
P/FCF 13.24
P/OCF 9.52
P/B 31.62
P/tB N/A
EV/EBITDA 9.97
EPS(TTM)11.25
EY6.16%
EPS(NY)14.55
Fwd EY7.97%
FCF(TTM)13.8
FCFY7.55%
OCF(TTM)19.2
OCFY10.51%
SpS96.87
BVpS5.78
TBVpS-47.13
PEG (NY)0.9
PEG (5Y)1.09
Profitability
Industry RankSector Rank
ROA 4.1%
ROE 132.42%
ROCE 23.13%
ROIC 17%
ROICexc 181.1%
ROICexgc N/A
OM 12.15%
PM (TTM) 7.9%
GM 89.58%
FCFM 14.25%
ROA(3y)3.61%
ROA(5y)-0.96%
ROE(3y)48.88%
ROE(5y)5.49%
ROIC(3y)10.99%
ROIC(5y)N/A
ROICexc(3y)20.29%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)14.96%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y125.83%
ROICexc growth 5Y22.57%
OM growth 3Y58.59%
OM growth 5Y8.82%
PM growth 3YN/A
PM growth 5Y14%
GM growth 3Y2.82%
GM growth 5Y1.74%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 5.34
Debt/FCF 3.11
Debt/EBITDA 1.74
Cap/Depr 90.29%
Cap/Sales 5.57%
Interest Coverage 7.92
Cash Conversion 108.18%
Profit Quality 180.4%
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 1.15
F-Score8
WACC8.31%
ROIC/WACC2.05
Cap/Depr(3y)92.88%
Cap/Depr(5y)87.19%
Cap/Sales(3y)5.93%
Cap/Sales(5y)8.19%
Profit Quality(3y)403.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.29%
EPS 3Y104.08%
EPS 5Y14.87%
EPS Q2Q%20.8%
EPS Next Y18.05%
EPS Next 2Y17.92%
EPS Next 3Y17.55%
EPS Next 5Y15.5%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y16.77%
Revenue growth 5Y2.56%
Sales Q2Q%6.41%
Revenue Next Year5.46%
Revenue Next 2Y5.98%
Revenue Next 3Y6.57%
Revenue Next 5Y6.25%
EBIT growth 1Y7.31%
EBIT growth 3Y85.19%
EBIT growth 5Y11.61%
EBIT Next Year134.06%
EBIT Next 3Y40.85%
EBIT Next 5Y27.05%
FCF growth 1Y-13.96%
FCF growth 3Y-8.85%
FCF growth 5Y7.7%
OCF growth 1Y-11.08%
OCF growth 3Y-6.28%
OCF growth 5Y2.2%